Guangzhou Baiy reported CNY4.73B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Aspen Pharmacare ZAR 10.14B 830M Jun/2024
Cipla INR 44.1B 5B Jun/2026
Dr.Reddys Laboratories INR 41.78B 4.02B Jun/2026
Jiangsu Hengrui CNY 7.05B 224.5M Mar/2026
Kalbe Farma IDR 3.66T 214.43B Mar/2026
Richter Gedeon HUF 143.37B 25.78B Sep/2025
Sh Fosun Pharma CNY 5.01B 1.69B Mar/2026
Sh Pharmaceutical CNY 8.09B 639.53M Mar/2026
Sun Pharmaceuticals INR 117.59B 7.65B Mar/2026
Teva Pharmaceutical Industries USD 2.15B 45M Jun/2026